Arista Wealth Management LLC Takes $503,000 Position in Zoetis Inc. $ZTS

Key Points

• Arista Wealth Management LLC has acquired a new position in Zoetis Inc., purchasing 3,228 shares worth approximately $503,000.
• The stock has seen significant interest from institutional investors, with 92.80% of shares owned by such entities, including Vanguard and Polen Capital Management, which have notably increased their positions.
• Zoetis announced a quarterly dividend of $0.50 per share, set to be paid on December 2nd, representing an annualized dividend yield of 1.4%.

Arista Wealth Management LLC bought a new stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 3,228 shares of the company's stock, valued at approximately $503,000.

Several other large investors have also recently modified their holdings of the stock. Vanguard Group Inc. increased its position in shares of Zoetis by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 41,556,164 shares of the company's stock valued at $6,842,222,000 after purchasing an additional 189,287 shares during the last quarter. Polen Capital Management LLC increased its position in shares of Zoetis by 17.6% during the 1st quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company's stock valued at $1,448,401,000 after purchasing an additional 1,313,653 shares during the last quarter. Northern Trust Corp increased its position in shares of Zoetis by 1.2% during the 1st quarter. Northern Trust Corp now owns 6,504,902 shares of the company's stock valued at $1,071,032,000 after purchasing an additional 78,508 shares during the last quarter. Goldman Sachs Group Inc. increased its position in shares of Zoetis by 2.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 5,146,024 shares of the company's stock valued at $847,293,000 after purchasing an additional 109,791 shares during the last quarter. Finally, Brown Advisory Inc. boosted its holdings in Zoetis by 7.6% during the 1st quarter. Brown Advisory Inc. now owns 4,408,542 shares of the company's stock valued at $725,866,000 after acquiring an additional 312,746 shares during the period. Institutional investors own 92.80% of the company's stock.

Analysts Set New Price Targets

ZTS has been the subject of a number of recent analyst reports. Weiss Ratings restated a "hold (c-)" rating on shares of Zoetis in a report on Wednesday, October 8th. Piper Sandler boosted their price objective on Zoetis from $210.00 to $215.00 and gave the company an "overweight" rating in a report on Monday, August 11th. Leerink Partnrs cut Zoetis from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 17th. Argus restated a "buy" rating and set a $190.00 price objective on shares of Zoetis in a report on Tuesday, September 9th. Finally, Leerink Partners cut Zoetis from an "outperform" rating to a "market perform" rating and dropped their price objective for the company from $180.00 to $155.00 in a report on Thursday, July 17th. Four equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $196.71.

Zoetis Price Performance

Shares of ZTS stock opened at $144.15 on Friday. Zoetis Inc. has a twelve month low of $139.34 and a twelve month high of $193.49. The stock has a market capitalization of $63.88 billion, a price-to-earnings ratio of 24.81, a P/E/G ratio of 2.30 and a beta of 0.90. The stock has a fifty day simple moving average of $148.73 and a two-hundred day simple moving average of $153.76. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05.

Zoetis (NYSE:ZTS - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.14. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business had revenue of $2.46 billion during the quarter, compared to analysts' expectations of $2.41 billion. During the same period in the prior year, the business earned $1.56 EPS. The business's revenue for the quarter was up 4.2% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis's payout ratio is presently 34.42%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.